2024-12-06 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Investment Report

**1. Performance Overview & Comparison to S&P 500 (VOO):**

Intuitive Surgical Inc. is a leading developer and manufacturer of robotic surgery systems.  The cumulative return of ISRG over the analyzed period is significantly higher than that of the S&P 500 (VOO). The difference is 207.8%, representing a substantial outperformance.  The relative outperformance, considering historical volatility, is at the 96th percentile.

| Metric                       | ISRG                     | VOO                       | Difference |
|-------------------------------|--------------------------|--------------------------|-------------|
| Cumulative Return            | 338.58%                  | 130.81%                  | 207.77%     |


**2. Recent Price Movement:**

* **Closing Price:** $547.65
* **5-Day Moving Average:** $544.83
* **20-Day Moving Average:** $539.39
* **60-Day Moving Average:** $509.37

The price is slightly above the 5 and 20-day moving averages, suggesting recent upward momentum.  It is significantly above the 60-day moving average indicating a longer-term upward trend.

**3. Technical Indicators & Expected Return:**

* **RSI:** 56.81  (Slightly above neutral; neither overbought nor oversold)
* **PPO:** -0.15 (Negative, suggesting bearish momentum in the short term)
* **20-Day Relative Divergence:**  `nan` (Missing data; cannot assess short-term trend based on this metric.)
* **Expected Return (Long-Term):** 122.4% (Significant outperformance compared to the S&P 500 over a 2+ year horizon.)

The relatively high expected return suggests strong potential for long-term growth, but the negative PPO indicator and missing divergence data caution against short-term bullishness.  The closing price of 547.56 doesn't represent a significant jump or drop given the recent trend.

**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue    | Revenue YoY Growth | EPS YoY Growth|
|------------|--------|------------|--------------------|-----------------|
| 2024-10-18 | $1.59  | $2.04B     | 17.2%               | 35%              |
| 2024-07-19 | $1.48  | $2.01B     | 15.5%               | 25%              |
| 2024-04-19 | $1.54  | $1.89B     | 10.4%                | 30%             |
| 2023-10-20 | $1.18  | $1.74B     | -           | -                |
| 2024-10-18 | $1.18  | $1.74B     | -           | -                |


**Analysis:**

* **Revenue Growth:**  Consistent year-over-year revenue growth is evident, indicating strong market demand and successful business expansion.
* **EPS Trends:** EPS also shows significant year-over-year growth across all the reported quarters.
* **Notable Beats/Misses:**  No information on expectations is provided, therefore no assessment on beats or misses is possible.


**5. Financial Information Analysis:**

The financial data reveals consistent profitability.  Revenue is growing steadily. The Profit Margin is consistently high, although showing minor fluctuations. Equity is also increasing, indicating sound financial health. Return on Equity (ROE) shows some variability, suggesting potential factors affecting profitability.  Further analysis beyond the provided data would be needed to draw stronger conclusions.

**6. News and Recent Issues:**  (Information not provided.  Analysis requires recent news headlines and analyst opinions.)

**7. Comprehensive Analysis:**

ISRG exhibits strong long-term growth potential based on its consistent revenue and earnings growth, high profit margins, and significantly positive historical performance relative to the S&P 500. While short-term indicators show mixed signals, the long-term outlook remains bullish, suggesting it may be a strong candidate for long-term investment. However, a comprehensive analysis requires incorporating recent news, analyst opinions, and a deeper dive into the financial statements to assess potential risks and future growth drivers.  The missing data in the report (relative divergence and detailed comparison to analystsâ€™ expectations) limits the scope of this analysis.

**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  The analysis is based solely on the limited data provided and should not be the sole basis for any investment decision.  Conduct thorough independent research before making any investment choices.
